BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2025 8:20:57 AM | Browse: 4 | Download: 1
 |
Received |
|
2025-08-08 05:59 |
|
Peer-Review Started |
|
2025-08-08 05:59 |
|
First Decision by Editorial Office Director |
|
2025-08-22 08:34 |
|
Return for Revision |
|
2025-08-22 08:34 |
|
Revised |
|
2025-09-05 02:27 |
|
Publication Fee Transferred |
|
2025-09-08 06:31 |
|
Second Decision by Editor |
|
2025-10-20 02:45 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-20 07:10 |
|
Articles in Press |
|
2025-10-20 07:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-26 09:36 |
|
Publish the Manuscript Online |
|
2025-12-11 08:20 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Long-term survival after treatment of gastric cancer with S-1 plus oxaliplatin regimen and sintilimab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jun Pan, Ping Li, Yu-He Zhou, Ting-Ting Pan, Yi-Tian Chen and Xiao-Yuan Chu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Yuan Chu, MD, Department of Oncology, Jinling Hospital, Medical School of Nanjing University, No. 305 Zhongshan East Road, Nanjing 210002, Jiangsu Province, China. chuxiaoyuan0@163.com |
| Key Words |
Metastatic gastric cancer; Sintilimab; Immunotherapy; Chemotherapy; Progression-free survival; Case report |
| Core Tip |
Chemotherapy combined with immunotherapy is the standard first-line treatment for metastatic gastric cancer. However, the first-line median progression-free survival is only about 7 months. This article reports a case of metastatic gastric cancer in which the patient received S-1 plus oxaliplatin regimen with sintilimab, followed by maintenance therapy with S-1 and sintilimab. The patient achieved a partial response and a progression-free survival of 23 months. Moreover, the treatment was temporarily paused for 6 months due to pneumonia. However, upon re-evaluation 6 months later, the tumor continued to regress. This combination therapy has shown encouraging results and warrants further study. |
| Publish Date |
2025-12-11 08:20 |
| Citation |
Pan J, Li P, Zhou YH, Pan TT, Chen YT, Chu XY. Long-term survival after treatment of gastric cancer with S-1 plus oxaliplatin regimen and sintilimab: A case report. World J Gastrointest Oncol 2025; 17(12): 112853 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i12/112853.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i12.112853 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
